Earnings Preview For Corcept Therapeutics
Portfolio Pulse from Benzinga Insights
Corcept Therapeutics (NASDAQ:CORT) is set to release its latest quarterly earnings report on August 2, 2023. Analysts estimate an earnings per share (EPS) of $0.15. The company's stock performance has been generally negative over the last 52-week period, with shares down 11.56%. Last quarter, the company missed EPS by $0.05, which was followed by a 3.9% increase in the share price the next day.
August 04, 2023 | 9:23 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Corcept Therapeutics is expected to report an EPS of $0.15 in its upcoming earnings. The company's shares have been down 11.56% over the last 52 weeks. Last quarter, the company missed EPS by $0.05, but the share price increased by 3.9% the next day.
The upcoming earnings report is a significant event for Corcept Therapeutics. While the company's shares have been down over the past year, the stock price increased after the last earnings report despite missing the EPS estimate. This suggests that investors may be more interested in other aspects of the company's performance, such as guidance. Therefore, the impact of the upcoming earnings report on the stock price is uncertain.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100